XML 30 R20.htm IDEA: XBRL DOCUMENT v3.25.2

Revenues (Tables)

6 Months Ended

Jun. 30, 2025

Revenue from Contract with Customer [Abstract]

Schedule of net product revenues by product

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2025 and 2024:

			Three months ended June 30,												Six months ended June 30,
			2025						2024						2025						2024
Products:
Kristalose			$	2,754,299					$	4,107,834					$	6,238,609					$	7,303,444
Sancuso			3,119,110						2,188,776						5,375,405						4,016,544
Vibativ			2,701,854						2,454,481						4,079,920						4,059,970
Caldolor			1,588,293						844,248						2,895,733						2,314,947
Acetadote			193,546						43,396						345,195						123,599
Vaprisol			(14,621)						(1,581)						(15,221)						7,081
Omeclamox-Pak			(752)						(941)						(6,139)						(2,556)
RediTrex			3,244						(1,156)						2,897						34,400
Other revenue			492,390						213,792						3,634,019						489,121
Total net revenues			$	10,837,363					$	9,848,849					$	22,550,418					$	18,346,550

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration